Table 6.
Evaluation Activities | Year of development n = 1360 guidelines |
Change | |
1994–1999 n = 730 % of guidelines (95% CI) |
2000–2005 n = 630 % of guidelines (95% CI) |
% | |
Effectiveness of dissemination/implementation was formally evaluated | 6.1 (4.4–7.8) | 12.2 (9.53–14.8) | +6.1 |
Plan to evaluate dissemination/implementation in future | 59.8 (55.7–63.9) | 22.7 (18.8–26.7) | -37.1 |
Guideline impact on health outcomes was formally evaluated | 5.1 (3.5–6.7) | 23.8 (20.4–27.3) | +18.7 |
Plan to evaluate guideline impact on health outcomes in future | 51.4 (47.3–55.6) | 32.6 (28.3–37.1) | -18.8 |
Companion document available for consumers | 21.3 (18.4–24.4) | 28.4 (24.9–31.9) | +7.1 |
Intend to produce consumer version in future | 24.3 (21.1–27.4) | 14.3 (11.6–17.0) | -10 |